Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.034
▾0.002 (5.56%)
Last trade: 02/12, 2:38AM
Market cap
$4.92m
20 min delay
Talk to Neuroscientific Biopharmaceuticals Ltd directly.
Sign up to their Investor Hub for direct access to the Neuroscientific Biopharmaceuticals Ltd team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
NeuroScientific Biopharmaceuticals Ltd (NSB) is developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's current R&D program is focused on developing a treatment for stroke-related brain injury and dementia / Alzheimer's disease, and a diagnostic for early-stage Alzheimer's disease. The Company's lead drug candidate, EmtinB, is a treatment for Alzheimer's disease. The Company also holds patents over 15mS.A., which has several novel capabilities that have the potential to translate into diagnostic processes for Alzheimer's Disease.
Address
Level 1/45 Stirling Hwy, Nedlands WA 6009, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.034
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.